Clinical Trial Update: Enteral Glutamine in Reducing Bloodstream Infections in Short Bowel Syndrome Infants [NA]

View source ↗

Summary

Completed clinical trial evaluating enteral glutamine for reducing bloodstream infections in infants with short bowel syndrome; results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bloodstream Infections
• Short Bowel Syndrome

Drugs mentioned

• Glutamine (glutamine)

Snippet

Sponsor: Children's Hospital Medical Center, Cincinnati | Conditions: Bloodstream Infections, Short Bowel Syndrome | NA | Status: COMPLETED | Results posted: 2020-06-11